Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 484 participants.

Also called NCT07613840

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 484 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07613840
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07613840. Randomized; no masking; primary purpose treatment. Start 2025-04-29 (actual); primary completion 2027-04-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Condition
Peripheral Arterial Disease (PAD)
Condition
Amputation
Condition
Thrombosis
Condition
Thrombosis (Stent Thrombosis)
Condition
Platelet Aggregation Inhibitors
Condition
Thromboelastography (TEG)
Condition
PRU(Platelet Reactivity Unit)
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Rivaroxaban
Intervention (Device)
Thromboelastography with Platelet Mapping
Lead sponsor
Massachusetts General Hospital (class: other)

Record details

Record id
cardio:ct-nct07613840
Content hash
657031e2419a2fdbaa568f17d5add04748187ee74350b0d905222f9c4ae2de4c